10/11/2023 12:47:54 PM - Perched near its all-time high. Fundamental concerns remain for this Swiss Drug company.

10/4/2023 12:39:38 PM - Gapped down today undercutting its 200 DMA line ($96), abruptly retreating from near its all-time high. Fundamental concerns remain for this Swiss Drug company.

10/3/2023 12:33:42 PM - Following M&A news it has been consolidating near its 50 DMA line ($102) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

10/2/2023 12:39:48 PM - Following M&A news it has been consolidating near its 50 DMA line ($102) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

9/29/2023 12:29:12 PM - Following M&A news it is consolidating near its 50 DMA line ($102) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

9/28/2023 1:03:28 PM - Following M&A news it is consolidating near its 50 DMA line ($102) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/26/2023 12:16:35 PM - Following M&A news it is consolidating above its 50 DMA line ($100) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/16/2023 1:04:19 PM - Following M&A news it is consolidating above its 50 DMA line ($100) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/12/2023 12:51:36 PM - Following M&A news it is still consolidating near its 50 DMA line ($99) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/6/2023 12:56:50 PM - Consolidating near its 50 DMA line ($99) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/5/2023 12:50:06 PM - Consolidating near its 50 DMA line ($98.75) after retreating from its all-time high. Fundamental concerns remain for this Swiss Drug company.

6/2/2023 12:43:48 PM - Pulled back from its all-time high and it is consolidating near its 50 DMA line. Fundamental concerns remain for this Swiss Drug company.

6/1/2023 12:48:16 PM - Pulling back from its all-time high and slumping below its 50 DMA line with this week's losses. Fundamental concerns remain for this Swiss Drug company.

5/31/2023 12:53:55 PM - Pulling back from its all-time high and slumping below its 50 DMA line with this week's losses. Fundamental concerns remain for this Swiss Drug company.

5/2/2023 12:51:00 PM - Perched near its all-time high following volume-driven gains. Fundamental concerns remain for this Swiss Drug company.